Abbott Laboratories/ US0028241000 /
10/4/2024 10:10:00 PM | Chg. +0.41 | Volume | Bid2:00:00 AM | Ask2:00:00 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
112.64USD | +0.37% | 4.37 mill. Turnover: 219.31 mill. |
112.54Bid Size: 100 | 113.50Ask Size: 100 | 195.98 bill.USD | 1.85% | 34.34 |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 3.28 USD | -16.75% |
EPS Diluted: | 3.26 USD | -16.62% |
Revenues per Share: | 23.12 USD | -7.97% |
Book Value per Share: | 22.38 USD | 5.38% |
Cash Flow per Share: | 4.18 USD | -24.09% |
Dividend per Share: | 2.08 USD | 8.33% |
Total | in mill. | |
Revenues: | 40,109.00 USD | -8.12% |
Net Income: | 5,723.00 USD | -17.45% |
Operating Cash Flow: | 7,261.00 USD | - |
Cash and Cash Equivalents: | 6,896.00 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 34.34 | 33.56 |
P/S Ratio: | 4.87 | 4.76 |
P/BV ratio: | 5.03 | 4.92 |
P/CF Ratio: | 26.92 | 26.30 |
PEG: | -2.05 | -2.00 |
Earnings Yield: | 2.91% | 2.98% |
Dividend Yield: | 1.85% | 1.89% |
Market Capitalization | ||
Market Capitalization: | 195.98 bill. USD | 190.99 bill. USD |
Free Float Market Cap.: | - USD | - USD |
Market Cap. / Employee: | - USD | - USD |
Shares Outstanding: | 1.74 bill. |
Profitability
Gross Profit Margin: | 55.18% |
EBIT Margin: | 16.15% |
Net Profit Margin: | 14.27% |
Return on Equity: | 14.74% |
Return on Assets: | 7.82% |
Financial Strength
Liquidity I / Cash Ratio: | 49.82% |
Liquidity II / Quick Ratio: | 97.25% |
Liquidity III / Current Ratio: | 163.79% |
Debt / Equity Ratio: | 88.56% |
Dynam. Debt / Equity Ratio: | 473.58% |
Efficiency
Employees: | - |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | - USD |
Net Income / Employee: | - USD |
Total Assets / Employee: | - USD |
* Fiscal Year End: | 12/31/2023 |
Accounting Standard: | US GAAP |
Currency: | USD |